Parekh, Jay
Parikh, Kaushal
Reuss, Joshua E.
Friedlaender, Alex
Addeo, Alfredo http://orcid.org/0000-0003-0988-0828
Funding for this research was provided by:
University of Geneva
Article History
Accepted: 4 May 2023
First Online: 30 May 2023
Declarations
:
: KP reports advisory board fees from Guardant Health and Jazz Pharmaceuticals. J.E. Reuss reports other support from Genentech/Roche, Sanofi/Genzyme, Personalis, and Guardant, grants from Genentech/Roche and Verastem, and personal fees from Astrazeneca outside the submitted work. A.F. reports consulting fees from Amgen, AstraZeneca, Roche, Astellas, Takeda, Bristol-Myers Squibb, Merck Sharpe Dohme, Pfizer, Merck, Novartis and Janssen. AA reports advisory board fees from Merck Sharpe Dohme, Roche, Takeda, Pfizer, Bristol-Myers Squibb, AstraZeneca, Eli-Lilly; speaker’s bureau fees from Eli-Lilly, AstraZeneca, Amgen.